Company / Interest Expense per Share
Fulgent Genetics, Inc. Interest Expense per Share History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2022
5-year range
$0.00 / $0.00
FY2020-FY2022
Trend
-6.6%
vs FY2021
Sector context
#44 of 43
Health Care
What the data says
Among 43 Health Care companies, Fulgent Genetics, Inc. is in the top -2% for interest expense per share. Improved from $0.00 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2022.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top -2% in Health CareTop -2% of 43This company $0.00 Sector average $1.48
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2022, interest expense per share decreased 6.6% year-over-year.
- Ranks #44 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.00 | -6.6% |
| FY2021 | $0.00 | -23.8% |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026